Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Mar;12(3):129-31.
doi: 10.1038/nrneph.2015.201. Epub 2015 Dec 14.

Transplantation: The role of RAAS blockade in kidney transplantation

Robert D Toto  1
Affiliations
Comment

Transplantation: The role of RAAS blockade in kidney transplantation

Robert D Toto. Nat Rev Nephrol. 2016 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests

R.D.T has received honoraria for consulting and advisory board activities from Boehringer–Ingelheim, Amgen, Celgene, Relypsa, and ZS Pharmaceuticals.

Comment on

References

    1. Gondos A, Dohler B, Brenner H, Opelz G. Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation. 2013;95:267–74. - PubMed
    1. Knoll GA, et al. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol. http://dx.doi.org/10.1016/S2213-8587(15)00368-X. - DOI - PubMed
    1. Lewis EJ, Hunsicker L, Bain R, et al. The Effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The New England journal of medicine. 1993;329:1456–1462. - PubMed
    1. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. The New England journal of medicine. 2001;345:851–60. - PubMed
    1. Heinze G, Mitterbauer C, Regele H, Kramar R, Winkelmayer WC, Curhan GC, Oberbauer R. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. Journal of the American Society of Nephrology : JASN. 2006;17:889–99. - PubMed

Publication types

MeSH terms

Substances